Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Hitoshi TERUI"'
Autor:
Saaya Yoshida-Akai, Taku Fujimura, Ryo Amagai, Yumi Kambayashi, Akira Hashimoto, Hitoshi Terui, Kenta Oka, Manami Watanabe-Takahashi, Emi Yamazaki, Kota Ohuchi, Yoshihide Asano
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1050-1054 (2024)
Introduction: Basal cell carcinoma (BCC) is a common skin cancer that rarely metastasizes but can deeply infiltrate local tissues. The small number of unresectable BCC cases makes it difficult to conduct clinical trials, resulting in delays in the de
Externí odkaz:
https://doaj.org/article/a196360f7f4e49218856123ea3439d3d
Autor:
Yusuke Muto, Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Chunbing Lyu, Hitoshi Terui, Masato Mizuashi, Setsuya Aiba, Yoshihide Asano
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 4, Pp 120-124 (2023)
Abstract Objectives Graft‐versus‐host disease (GVHD) is an important complication of bone marrow transplantation. Recent reports suggest the significance of T‐cell subsets (Th1, Th17, and cytotoxic CD8+ T cells) as well as CD163+ macrophages in
Externí odkaz:
https://doaj.org/article/dfdeac72e7b441029f40c116fa4b397a
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 419-421 (2023)
Olaparib is recently approved as an anti-tumor agent for several cancers, including castration-resistant prostate cancer, which inhibits poly (adenosine diphosphate-ribose) polymerase, a DNA repair factor. Since olaparib is a newly approved drug, the
Externí odkaz:
https://doaj.org/article/baea235b61f747a0823473110f7e1d87
Publikováno v:
Case Reports in Dermatology, Vol 15, Iss 1, Pp 22-25 (2023)
Palmoplantar pustulosis (PPP) is a chronic skin inflammatory disease in which blisters and pustules repeatedly develop on palms and soles. PPP is often refractory to topical therapy, oral therapy, phototherapy, and biologics that are usually applied
Externí odkaz:
https://doaj.org/article/f3a9f927360e4d0b9afe91a2643619b0
Autor:
Ryo Amagai, Toshiya Takahashi, Hitoshi Terui, Taku Fujimura, Kenshi Yamasaki, Setsuya Aiba, Yoshihide Asano
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 875 (2023)
An active form of cathelicidin antimicrobial peptide, LL-37, has immunomodulatory and stimulatory effects, though the specific pathways are not clear. The purpose of this study was to identify the cellular pathways by which LL-37 amplifies the inflam
Externí odkaz:
https://doaj.org/article/8548af6475cf42f9a69952c861b62e41
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 9, p adv00536 (2021)
Externí odkaz:
https://doaj.org/article/645b5bbabe66460ba5f7fcde7aa89bf2
Autor:
Takuya Izumiyama, Yu Mori, Itsuki Oizumi, Soshi Hamada, Hiroaki Kurishima, Hitoshi Terui, Ryoko Omori-Shimada, Kenshi Yamasaki, Eiji Itoi
Publikováno v:
Journal of Orthopaedic Surgery, Vol 29 (2021)
Objectives: The patient of severe psoriatic arthritis (PsA) is mainly treated with oral methotrexate, ciclosporin, and anti-tumor necrosis factor-alpha inhibitors (TNFi). Recently, anti-interleukin-17A inhibitors (IL-17Ai) have been used in the treat
Externí odkaz:
https://doaj.org/article/65b75ce44eef42119609e35cf50c9061
Publikováno v:
Case Reports in Dermatology, Vol 8, Iss 1, Pp 52-58 (2016)
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma that only rarely regresses spontaneously. Since little is known about the immunological mechanisms involved in the spontaneous regression of MCC, we describe a case of MCC with spo
Externí odkaz:
https://doaj.org/article/21b533fa1c3d47dbba45a1d37d69da2c
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 1, Pp 128-129 (2017)
Externí odkaz:
https://doaj.org/article/7b5017529f6b4f1bba8ea39e0e758000
Publikováno v:
Current Opinion in Rheumatology; Nov2023, Vol. 35 Issue 6, p317-323, 7p